Table of Content

1 Gastric Motility Disorder Drug Market Overview
1.1 Gastric Motility Disorder Drug Product Scope
1.2 Gastric Motility Disorder Drug Segment by Type
1.2.1 Global Gastric Motility Disorder Drug Sales by Type (2016 & 2021 & 2027)
1.2.2 Velusetrag
1.2.3 Ipamorelin
1.2.4 TD-8954
1.2.5 Others
1.3 Gastric Motility Disorder Drug Segment by Application
1.3.1 Global Gastric Motility Disorder Drug Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Home Use
1.4 Gastric Motility Disorder Drug Market Estimates and Forecasts (2016-2027)
1.4.1 Global Gastric Motility Disorder Drug Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Gastric Motility Disorder Drug Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Gastric Motility Disorder Drug Price Trends (2016-2027)

2 Gastric Motility Disorder Drug Estimates and Forecasts by Region
2.1 Global Gastric Motility Disorder Drug Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Gastric Motility Disorder Drug Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Gastric Motility Disorder Drug Sales Market Share by Region (2016-2021)
2.2.2 Global Gastric Motility Disorder Drug Revenue Market Share by Region (2016-2021)
2.3 Global Gastric Motility Disorder Drug Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Gastric Motility Disorder Drug Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Gastric Motility Disorder Drug Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Gastric Motility Disorder Drug Estimates and Projections (2016-2027)
2.4.2 Europe Gastric Motility Disorder Drug Estimates and Projections (2016-2027)
2.4.3 China Gastric Motility Disorder Drug Estimates and Projections (2016-2027)
2.4.4 Japan Gastric Motility Disorder Drug Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Gastric Motility Disorder Drug Estimates and Projections (2016-2027)
2.4.6 India Gastric Motility Disorder Drug Estimates and Projections (2016-2027)

3 Global Gastric Motility Disorder Drug Competition Landscape by Players
3.1 Global Top Gastric Motility Disorder Drug Players by Sales (2016-2021)
3.2 Global Top Gastric Motility Disorder Drug Players by Revenue (2016-2021)
3.3 Global Gastric Motility Disorder Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gastric Motility Disorder Drug as of 2020)
3.4 Global Gastric Motility Disorder Drug Average Price by Company (2016-2021)
3.5 Manufacturers Gastric Motility Disorder Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Gastric Motility Disorder Drug Market Size by Type
4.1 Global Gastric Motility Disorder Drug Historic Market Review by Type (2016-2021)
4.1.1 Global Gastric Motility Disorder Drug Sales Market Share by Type (2016-2021)
4.1.2 Global Gastric Motility Disorder Drug Revenue Market Share by Type (2016-2021)
4.1.3 Global Gastric Motility Disorder Drug Price by Type (2016-2021)
4.2 Global Gastric Motility Disorder Drug Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Gastric Motility Disorder Drug Sales Forecast by Type (2022-2027)
4.2.2 Global Gastric Motility Disorder Drug Revenue Forecast by Type (2022-2027)
4.2.3 Global Gastric Motility Disorder Drug Price Forecast by Type (2022-2027)

5 Global Gastric Motility Disorder Drug Market Size by Application
5.1 Global Gastric Motility Disorder Drug Historic Market Review by Application (2016-2021)
5.1.1 Global Gastric Motility Disorder Drug Sales Market Share by Application (2016-2021)
5.1.2 Global Gastric Motility Disorder Drug Revenue Market Share by Application (2016-2021)
5.1.3 Global Gastric Motility Disorder Drug Price by Application (2016-2021)
5.2 Global Gastric Motility Disorder Drug Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Gastric Motility Disorder Drug Sales Forecast by Application (2022-2027)
5.2.2 Global Gastric Motility Disorder Drug Revenue Forecast by Application (2022-2027)
5.2.3 Global Gastric Motility Disorder Drug Price Forecast by Application (2022-2027)

6 North America Gastric Motility Disorder Drug Market Facts & Figures
6.1 North America Gastric Motility Disorder Drug Sales by Company
6.1.1 North America Gastric Motility Disorder Drug Sales by Company (2016-2021)
6.1.2 North America Gastric Motility Disorder Drug Revenue by Company (2016-2021)
6.2 North America Gastric Motility Disorder Drug Sales Breakdown by Type
6.2.1 North America Gastric Motility Disorder Drug Sales Breakdown by Type (2016-2021)
6.2.2 North America Gastric Motility Disorder Drug Sales Breakdown by Type (2022-2027)
6.3 North America Gastric Motility Disorder Drug Sales Breakdown by Application
6.3.1 North America Gastric Motility Disorder Drug Sales Breakdown by Application (2016-2021)
6.3.2 North America Gastric Motility Disorder Drug Sales Breakdown by Application (2022-2027)

7 Europe Gastric Motility Disorder Drug Market Facts & Figures
7.1 Europe Gastric Motility Disorder Drug Sales by Company
7.1.1 Europe Gastric Motility Disorder Drug Sales by Company (2016-2021)
7.1.2 Europe Gastric Motility Disorder Drug Revenue by Company (2016-2021)
7.2 Europe Gastric Motility Disorder Drug Sales Breakdown by Type
7.2.1 Europe Gastric Motility Disorder Drug Sales Breakdown by Type (2016-2021)
7.2.2 Europe Gastric Motility Disorder Drug Sales Breakdown by Type (2022-2027)
7.3 Europe Gastric Motility Disorder Drug Sales Breakdown by Application
7.3.1 Europe 116 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 116 Sales Breakdown by Application (2022-2027)

8 China Gastric Motility Disorder Drug Market Facts & Figures
8.1 China Gastric Motility Disorder Drug Sales by Company
8.1.1 China Gastric Motility Disorder Drug Sales by Company (2016-2021)
8.1.2 China Gastric Motility Disorder Drug Revenue by Company (2016-2021)
8.2 China Gastric Motility Disorder Drug Sales Breakdown by Type
8.2.1 China Gastric Motility Disorder Drug Sales Breakdown by Type (2016-2021)
8.2.2 China Gastric Motility Disorder Drug Sales Breakdown by Type (2022-2027)
8.3 China Gastric Motility Disorder Drug Sales Breakdown by Application
8.3.1 China 146 Sales Breakdown by Application (2016-2021)
8.3.2 China 146 Sales Breakdown by Application (2022-2027)

9 Japan Gastric Motility Disorder Drug Market Facts & Figures
9.1 Japan Gastric Motility Disorder Drug Sales by Company
9.1.1 Japan Gastric Motility Disorder Drug Sales by Company (2016-2021)
9.1.2 Japan Gastric Motility Disorder Drug Revenue by Company (2016-2021)
9.2 Japan Gastric Motility Disorder Drug Sales Breakdown by Type
9.2.1 Japan Gastric Motility Disorder Drug Sales Breakdown by Type (2016-2021)
9.2.2 Japan Gastric Motility Disorder Drug Sales Breakdown by Type (2022-2027)
9.3 Japan Gastric Motility Disorder Drug Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Gastric Motility Disorder Drug Market Facts & Figures
10.1 Southeast Asia Gastric Motility Disorder Drug Sales by Company
10.1.1 Southeast Asia Gastric Motility Disorder Drug Sales by Company (2016-2021)
10.1.2 Southeast Asia Gastric Motility Disorder Drug Revenue by Company (2016-2021)
10.2 Southeast Asia Gastric Motility Disorder Drug Sales Breakdown by Type
10.2.1 Southeast Asia Gastric Motility Disorder Drug Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Gastric Motility Disorder Drug Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Gastric Motility Disorder Drug Sales Breakdown by Application
10.3.1 Southeast Asia K Pcs Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Pcs Sales Breakdown by Application (2022-2027)

11 India Gastric Motility Disorder Drug Market Facts & Figures
11.1 India Gastric Motility Disorder Drug Sales by Company
11.1.1 India Gastric Motility Disorder Drug Sales by Company (2016-2021)
11.1.2 India Gastric Motility Disorder Drug Revenue by Company (2016-2021)
11.2 India Gastric Motility Disorder Drug Sales Breakdown by Type
11.2.1 India Gastric Motility Disorder Drug Sales Breakdown by Type (2016-2021)
11.2.2 India Gastric Motility Disorder Drug Sales Breakdown by Type (2022-2027)
11.3 India Gastric Motility Disorder Drug Sales Breakdown by Application
11.3.1 India Gastric Motility Disorder Drug Sales Breakdown by Application (2016-2021)
11.3.2 India Gastric Motility Disorder Drug Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Gastric Motility Disorder Drug Business
12.1 Theravance, Inc.
12.1.1 Theravance, Inc. Corporation Information
12.1.2 Theravance, Inc. Business Overview
12.1.3 Theravance, Inc. Gastric Motility Disorder Drug Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Theravance, Inc. Gastric Motility Disorder Drug Products Offered
12.1.5 Theravance, Inc. Recent Development
12.2 Helsinn Healthcare S.A.
12.2.1 Helsinn Healthcare S.A. Corporation Information
12.2.2 Helsinn Healthcare S.A. Business Overview
12.2.3 Helsinn Healthcare S.A. Gastric Motility Disorder Drug Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Helsinn Healthcare S.A. Gastric Motility Disorder Drug Products Offered
12.2.5 Helsinn Healthcare S.A. Recent Development
12.3 Concert Pharmaceuticals, Inc.
12.3.1 Concert Pharmaceuticals, Inc. Corporation Information
12.3.2 Concert Pharmaceuticals, Inc. Business Overview
12.3.3 Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Products Offered
12.3.5 Concert Pharmaceuticals, Inc. Recent Development
12.4 Targacept, Inc.
12.4.1 Targacept, Inc. Corporation Information
12.4.2 Targacept, Inc. Business Overview
12.4.3 Targacept, Inc. Gastric Motility Disorder Drug Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Targacept, Inc. Gastric Motility Disorder Drug Products Offered
12.4.5 Targacept, Inc. Recent Development
12.5 ChironWells GmbH
12.5.1 ChironWells GmbH Corporation Information
12.5.2 ChironWells GmbH Business Overview
12.5.3 ChironWells GmbH Gastric Motility Disorder Drug Sales, Revenue and Gross Margin (2016-2021)
12.5.4 ChironWells GmbH Gastric Motility Disorder Drug Products Offered
12.5.5 ChironWells GmbH Recent Development
...

13 Gastric Motility Disorder Drug Manufacturing Cost Analysis
13.1 Gastric Motility Disorder Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Gastric Motility Disorder Drug
13.4 Gastric Motility Disorder Drug Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Gastric Motility Disorder Drug Distributors List
14.3 Gastric Motility Disorder Drug Customers

15 Market Dynamics
15.1 Gastric Motility Disorder Drug Market Trends
15.2 Gastric Motility Disorder Drug Drivers
15.3 Gastric Motility Disorder Drug Market Challenges
15.4 Gastric Motility Disorder Drug Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Gastric Motility Disorder Drug Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Gastric Motility Disorder Drug Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Gastric Motility Disorder Drug Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Gastric Motility Disorder Drug Sales (K Pcs) by Region (2016-2021)
Table 5. Global Gastric Motility Disorder Drug Sales Market Share by Region (2016-2021)
Table 6. Global Gastric Motility Disorder Drug Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Gastric Motility Disorder Drug Revenue Share by Region (2016-2021)
Table 8. Global Gastric Motility Disorder Drug Sales (K Pcs) Forecast by Region (2022-2027)
Table 9. Global Gastric Motility Disorder Drug Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Gastric Motility Disorder Drug Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Gastric Motility Disorder Drug Revenue Share Forecast by Region (2022-2027)
Table 12. Global Gastric Motility Disorder Drug Sales (K Pcs) of Key Companies (2016-2021)
Table 13. Global Gastric Motility Disorder Drug Sales Share by Company (2016-2021)
Table 14. Global Gastric Motility Disorder Drug Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Gastric Motility Disorder Drug Revenue Share by Company (2016-2021)
Table 16. Global Gastric Motility Disorder Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastric Motility Disorder Drug as of 2020)
Table 17. Global Gastric Motility Disorder Drug Average Price (USD/Pcs) of Key Company (2016-2021)
Table 18. Manufacturers Gastric Motility Disorder Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Gastric Motility Disorder Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Gastric Motility Disorder Drug Sales (K Pcs) by Type (2016-2021)
Table 22. Global Gastric Motility Disorder Drug Sales Share by Type (2016-2021)
Table 23. Global Gastric Motility Disorder Drug Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Gastric Motility Disorder Drug Price (USD/Pcs) by Type (2016-2021)
Table 25. Global Gastric Motility Disorder Drug Sales Share by Type (2022-2027)
Table 26. Global Gastric Motility Disorder Drug Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Gastric Motility Disorder Drug Revenue Share by Type (2022-2027)
Table 28. Global Gastric Motility Disorder Drug Price (USD/Pcs) by Type (2022-2027)
Table 29. Global Gastric Motility Disorder Drug Sales (K Pcs) by Application (2016-2021)
Table 30. Global Gastric Motility Disorder Drug Sales Share by Application (2016-2021)
Table 31. Global Gastric Motility Disorder Drug Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Gastric Motility Disorder Drug Price (USD/Pcs) by Application (2016-2021)
Table 33. Global Gastric Motility Disorder Drug Sales (K Pcs) by Application (2022-2027)
Table 34. Global Gastric Motility Disorder Drug Sales Share by Application (2022-2027)
Table 35. Global Gastric Motility Disorder Drug Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Gastric Motility Disorder Drug Revenue Share by Application (2022-2027)
Table 37. Global Gastric Motility Disorder Drug Price (USD/Pcs) by Application (2022-2027)
Table 38. North America Gastric Motility Disorder Drug Sales (K Pcs) by Company (2016-2021)
Table 39. North America Gastric Motility Disorder Drug Sales Market Share by Company (2016-2021)
Table 40. North America Gastric Motility Disorder Drug Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Gastric Motility Disorder Drug Revenue Market Share by Company (2016-2021)
Table 42. North America Gastric Motility Disorder Drug Sales by Type (2016-2021) & (K Pcs)
Table 43. North America Gastric Motility Disorder Drug Sales Market Share by Type (2016-2021)
Table 44. North America Gastric Motility Disorder Drug Sales by Type (2022-2027) & (K Pcs)
Table 45. North America Gastric Motility Disorder Drug Sales Market Share by Type (2022-2027)
Table 46. North America Gastric Motility Disorder Drug Sales by Application (2016-2021) & (K Pcs)
Table 47. North America Gastric Motility Disorder Drug Sales Market Share by Application (2016-2021)
Table 48. North America Gastric Motility Disorder Drug Sales by Application (2022-2027) & (K Pcs)
Table 49. North America Gastric Motility Disorder Drug Sales Market Share by Application (2022-2027)
Table 50. Europe Gastric Motility Disorder Drug Sales (K Pcs) by Company (2016-2021)
Table 51. Europe Gastric Motility Disorder Drug Sales Market Share by Company (2016-2021)
Table 52. Europe Gastric Motility Disorder Drug Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Gastric Motility Disorder Drug Revenue Market Share by Company (2016-2021)
Table 54. Europe Gastric Motility Disorder Drug Sales by Type (2016-2021) & (K Pcs)
Table 55. Europe Gastric Motility Disorder Drug Sales Market Share by Type (2016-2021)
Table 56. Europe Gastric Motility Disorder Drug Sales by Type (2022-2027) & (K Pcs)
Table 57. Europe Gastric Motility Disorder Drug Sales Market Share by Type (2022-2027)
Table 58. Europe Gastric Motility Disorder Drug Sales by Application (2016-2021) & (K Pcs)
Table 59. Europe Gastric Motility Disorder Drug Sales Market Share by Application (2016-2021)
Table 60. Europe Gastric Motility Disorder Drug Sales by Application (2022-2027) & (K Pcs)
Table 61. Europe Gastric Motility Disorder Drug Sales Market Share by Application (2022-2027)
Table 62. China Gastric Motility Disorder Drug Sales (K Pcs) by Company (2016-2021)
Table 63. China Gastric Motility Disorder Drug Sales Market Share by Company (2016-2021)
Table 64. China Gastric Motility Disorder Drug Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Gastric Motility Disorder Drug Revenue Market Share by Company (2016-2021)
Table 66. China Gastric Motility Disorder Drug Sales by Type (2016-2021) & (K Pcs)
Table 67. China Gastric Motility Disorder Drug Sales Market Share by Type (2016-2021)
Table 68. China Gastric Motility Disorder Drug Sales by Type (2022-2027) & (K Pcs)
Table 69. China Gastric Motility Disorder Drug Sales Market Share by Type (2022-2027)
Table 70. China Gastric Motility Disorder Drug Sales by Application (2016-2021) & (K Pcs)
Table 71. China Gastric Motility Disorder Drug Sales Market Share by Application (2016-2021)
Table 72. China Gastric Motility Disorder Drug Sales by Application (2022-2027) & (K Pcs)
Table 73. China Gastric Motility Disorder Drug Sales Market Share by Application (2022-2027)
Table 74. Japan Gastric Motility Disorder Drug Sales (K Pcs) by Company (2016-2021)
Table 75. Japan Gastric Motility Disorder Drug Sales Market Share by Company (2016-2021)
Table 76. Japan Gastric Motility Disorder Drug Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Gastric Motility Disorder Drug Revenue Market Share by Company (2016-2021)
Table 78. Japan Gastric Motility Disorder Drug Sales by Type (2016-2021) & (K Pcs)
Table 79. Japan Gastric Motility Disorder Drug Sales Market Share by Type (2016-2021)
Table 80. Japan Gastric Motility Disorder Drug Sales by Type (2022-2027) & (K Pcs)
Table 81. Japan Gastric Motility Disorder Drug Sales Market Share by Type (2022-2027)
Table 82. Japan Gastric Motility Disorder Drug Sales by Application (2016-2021) & (K Pcs)
Table 83. Japan Gastric Motility Disorder Drug Sales Market Share by Application (2016-2021)
Table 84. Japan Gastric Motility Disorder Drug Sales by Application (2022-2027) & (K Pcs)
Table 85. Japan Gastric Motility Disorder Drug Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Gastric Motility Disorder Drug Sales (K Pcs) by Company (2016-2021)
Table 87. Southeast Asia Gastric Motility Disorder Drug Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Gastric Motility Disorder Drug Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Gastric Motility Disorder Drug Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Gastric Motility Disorder Drug Sales by Type (2016-2021) & (K Pcs)
Table 91. Southeast Asia Gastric Motility Disorder Drug Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Gastric Motility Disorder Drug Sales by Type (2022-2027) & (K Pcs)
Table 93. Southeast Asia Gastric Motility Disorder Drug Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Gastric Motility Disorder Drug Sales by Application (2016-2021) & (K Pcs)
Table 95. Southeast Asia Gastric Motility Disorder Drug Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Gastric Motility Disorder Drug Sales by Application (2022-2027) & (K Pcs)
Table 97. Southeast Asia Gastric Motility Disorder Drug Sales Market Share by Application (2022-2027)
Table 98. India Gastric Motility Disorder Drug Sales (K Pcs) by Company (2016-2021)
Table 99. India Gastric Motility Disorder Drug Sales Market Share by Company (2016-2021)
Table 100. India Gastric Motility Disorder Drug Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Gastric Motility Disorder Drug Revenue Market Share by Company (2016-2021)
Table 102. India Gastric Motility Disorder Drug Sales by Type (2016-2021) & (K Pcs)
Table 103. India Gastric Motility Disorder Drug Sales Market Share by Type (2016-2021)
Table 104. India Gastric Motility Disorder Drug Sales by Type (2022-2027) & (K Pcs)
Table 105. India Gastric Motility Disorder Drug Sales Market Share by Type (2022-2027)
Table 106. India Gastric Motility Disorder Drug Sales by Application (2016-2021) & (K Pcs)
Table 107. India Gastric Motility Disorder Drug Sales Market Share by Application (2016-2021)
Table 108. India Gastric Motility Disorder Drug Sales by Application (2022-2027) & (K Pcs)
Table 109. India Gastric Motility Disorder Drug Sales Market Share by Application (2022-2027)
Table 110. Theravance, Inc. Corporation Information
Table 111. Theravance, Inc. Description and Business Overview
Table 112. Theravance, Inc. Gastric Motility Disorder Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 113. Theravance, Inc. Gastric Motility Disorder Drug Product
Table 114. Theravance, Inc. Recent Development
Table 115. Helsinn Healthcare S.A. Corporation Information
Table 116. Helsinn Healthcare S.A. Description and Business Overview
Table 117. Helsinn Healthcare S.A. Gastric Motility Disorder Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 118. Helsinn Healthcare S.A. Gastric Motility Disorder Drug Product
Table 119. Helsinn Healthcare S.A. Recent Development
Table 120. Concert Pharmaceuticals, Inc. Corporation Information
Table 121. Concert Pharmaceuticals, Inc. Description and Business Overview
Table 122. Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 123. Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Product
Table 124. Concert Pharmaceuticals, Inc. Recent Development
Table 125. Targacept, Inc. Corporation Information
Table 126. Targacept, Inc. Description and Business Overview
Table 127. Targacept, Inc. Gastric Motility Disorder Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 128. Targacept, Inc. Gastric Motility Disorder Drug Product
Table 129. Targacept, Inc. Recent Development
Table 130. ChironWells GmbH Corporation Information
Table 131. ChironWells GmbH Description and Business Overview
Table 132. ChironWells GmbH Gastric Motility Disorder Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 133. ChironWells GmbH Gastric Motility Disorder Drug Product
Table 134. ChironWells GmbH Recent Development
Table 135. Production Base and Market Concentration Rate of Raw Material
Table 136. Key Suppliers of Raw Materials
Table 137. Gastric Motility Disorder Drug Distributors List
Table 138. Gastric Motility Disorder Drug Customers List
Table 139. Gastric Motility Disorder Drug Market Trends
Table 140. Gastric Motility Disorder Drug Market Drivers
Table 141. Gastric Motility Disorder Drug Market Challenges
Table 142. Gastric Motility Disorder Drug Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Gastric Motility Disorder Drug Product Picture
Figure 2. Global Gastric Motility Disorder Drug Sales Market Share by Type in 2021 & 2027
Figure 3. Velusetrag Product Picture
Figure 4. Ipamorelin Product Picture
Figure 5. TD-8954 Product Picture
Figure 6. Others Product Picture
Figure 7. Global Gastric Motility Disorder Drug Sales Market Share by Application in 2021 & 2027
Figure 8. Hospital Examples
Figure 9. Clinic Examples
Figure 10. Home Use Examples
Figure 11. Global Gastric Motility Disorder Drug Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Gastric Motility Disorder Drug Sales Growth Rate (2016-2027) & (US$ Million)
Figure 13. Global Gastric Motility Disorder Drug Sales (K Pcs) Growth Rate (2016-2027)
Figure 14. Global Gastric Motility Disorder Drug Price Trends Growth Rate (2016-2027) (USD/Pcs)
Figure 15. Global Gastric Motility Disorder Drug Revenue Market Share by Region: 2016 VS 2021
Figure 16. Global Gastric Motility Disorder Drug Revenue Market Share by Region: 2021 VS 2027
Figure 17. North America Gastric Motility Disorder Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. North America Gastric Motility Disorder Drug Sales (K Pcs) Growth Rate (2016-2027)
Figure 19. Europe Gastric Motility Disorder Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. Europe Gastric Motility Disorder Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 21. China Gastric Motility Disorder Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. China Gastric Motility Disorder Drug Sales (Million USD) and Growth Rate (2016-2027)
Figure 23. Japan Gastric Motility Disorder Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Japan Gastric Motility Disorder Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Gastric Motility Disorder Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. Southeast Asia Gastric Motility Disorder Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 27. India Gastric Motility Disorder Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 28. India Gastric Motility Disorder Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 29. Global 5 Largest Gastric Motility Disorder Drug Players Market Share by Revenue in Gastric Motility Disorder Drug: 2016 & 2020
Figure 30. Gastric Motility Disorder Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 31. Global Gastric Motility Disorder Drug Revenue Share by Type (2016-2021)
Figure 32. Global Gastric Motility Disorder Drug Revenue Growth Rate by Type in 2016 & 2020
Figure 33. Global Gastric Motility Disorder Drug Revenue Share by Application (2016-2021)
Figure 34. Global Gastric Motility Disorder Drug Revenue Growth Rate by Application in 2016 & 2020
Figure 35. North America Gastric Motility Disorder Drug Sales Market Share by Type in 2020
Figure 36. North America Gastric Motility Disorder Drug Sales Market Share by Application in 2020
Figure 37. Europe Gastric Motility Disorder Drug Sales Market Share by Type in 2020
Figure 38. Europe Gastric Motility Disorder Drug Sales Market Share by Application in 2020
Figure 39. China Gastric Motility Disorder Drug Sales Market Share by Type in 2020
Figure 40. China Gastric Motility Disorder Drug Sales Market Share by Application in 2020
Figure 41. Japan Gastric Motility Disorder Drug Sales Market Share by Type in 2020
Figure 42. Japan Gastric Motility Disorder Drug Sales Market Share by Application in 2020
Figure 43. Southeast Asia Gastric Motility Disorder Drug Sales Market Share by Type in 2020
Figure 44. Southeast Asia Gastric Motility Disorder Drug Sales Market Share by Application in 2020
Figure 45. India Gastric Motility Disorder Drug Sales Market Share by Type in 2020
Figure 46. India Gastric Motility Disorder Drug Sales Market Share by Application in 2020
Figure 47. Key Raw Materials Price Trend
Figure 48. Manufacturing Cost Structure of Gastric Motility Disorder Drug
Figure 49. Manufacturing Process Analysis of Gastric Motility Disorder Drug
Figure 50. Gastric Motility Disorder Drug Industrial Chain Analysis
Figure 51. Channels of Distribution
Figure 52. Distributors Profiles
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed